or Try an Advanced Search...

    Cancer Treatment Stocks List

    Symbol Grade Name % Change
    GLSI F Greenwich LifeSciences, Inc. 0.93
    ANIX F Anixa Biosciences, Inc. 0.49
    ORIC F Oric Pharmaceuticals, Inc. 4.35
    ATOS F Atossa Genetics Inc. -0.83
    NXTC F NextCure, Inc. -0.77
    YMAB F Y-mAbs Therapeutics, Inc. -4.17
    IOVA F Iovance Biotherapeutics, Inc. 1.23
    BYSI F BeyondSpring, Inc. 1.75
    STRO F Sutro Biopharma, Inc. -5.24
    CRDF F Cardiff Oncology, Inc. -1.19
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Insurance - Diversified Medical Instruments & Supplies
    Related Stock Lists: Cancer Medicine Clinical Medicine Antineoplastic Drugs Biotechnology Biopharmaceutical Immune System Immunotherapy Solid Tumors Advanced Solid Tumors Cancer Cell Cancer Immunotherapy Cancer Immunotherapy Product Checkpoint Inhibitor Chemotherapy Drugs Epidermal Growth Factor Receptor Immunotherapy Products Lymphoma Milatuzumab

    Related ETFs - A few ETFs which own one or more of the above listed Cancer Treatment stocks.

    Symbol Grade Name Weight
    FTXH D First Trust Nasdaq Pharmaceuticals ETF 8.89
    MEDX F Horizon Kinetics Medical ETF 6.23
    PPH D Market Vectors Pharmaceutical ETF 5.89
    MVAL B SHL Telemedicine Ltd VanEck Morningstar Wide Moat Value ETF 5.37
    RDIV A RevenueShares Ultra Dividend Fund 5.27
    View all Cancer Treatment ETFs...
    Compare ETFs
    Compare MEDX to PPH Compare MVAL to RDIV Compare PPH to RDIV

        Cancer Treatment Stocks Recent News

        Date Stock Title
        Nov 21 ATOS Atossa Therapeutics to Present Poster on (Z)-Endoxifen at AACR Special Conference in Cancer Research
        Nov 20 ATOS Atossa Therapeutics Announces Five Abstracts Highlighting (Z)-Endoxifen Research Accepted for Presentation at the 2024 San Antonio Breast Cancer Symposium
        Nov 19 NXTC Preclinical Data Demonstrates Anti-Siglec-15 Treatment Enhanced Generation of Quality Bone with Better Mechanical Properties in Mice with Moderate-to-Severe Osteogenesis Imperfecta
        Nov 19 CRDF Cardiff Oncology Announces New Patent with Claims for the Use of Onvansertib in Treating KRAS mutated mCRC
        Nov 18 STRO Sutro Biopharma (STRO) Upgraded to Buy: Here's What You Should Know
        Nov 18 ATOS Is Intuitive Surgical (ISRG) Outperforming Other Medical Stocks This Year?
        Nov 18 ANIX Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial
        Nov 15 STRO Sutro Biopharma Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Insurance - Diversified Medical Instruments & Supplies
        Related Stock Lists: Cancer Biopharmaceutical Clinical Medicine Antineoplastic Drugs Medicine Solid Tumors Melanoma Advanced Non Small Cell Lung Cancer Biotechnology Cancer Immunotherapy Cancer Therapies Epidermal Growth Factor Receptor Multiple Myeloma NSCLC Non Small Cell Lung Cancer Organic Chemistry Orphan Drug Protein Kinase Small Cell Lung Cancer Acid
        Cancer Treatment

        Cancer treatment is the use of medical therapies to treat cancer. These treatments may include surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapy. The goal of cancer treatment is to remove or destroy the cancer cells, reduce symptoms, and improve quality of life.

        Browse All Tags